Skip to content
healthcare.dev
Get a free key

RELENZA

NDC 0173-0681, zanamivir, powder, from GlaxoSmithKline LLC.

Product NDC
0173-0681
Status
Listed
Labeler
GlaxoSmithKline LLC
Dosage form
POWDER
Route
RESPIRATORY (INHALATION)
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA021036
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0173-0681 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ZANAMIVIR5 mg/1

Pharmacologic classes

Neuraminidase Inhibitor [EPC]; Neuraminidase Inhibitors [MoA]

Package NDCNDC-11Package
0173-0681-01001730681015 PACKAGE in 1 CARTON (0173-0681-01) / 4 POWDER in 1 PACKAGE
0173-0681-22001730681225 PACKAGE in 1 CARTON (0173-0681-22) / 4 POWDER in 1 PACKAGE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d7c3bcc3-0c0d-4068-fd80-88cf54a376ef

Use it

Look up 0173-0681 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0173-0681 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0173-0681. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.